Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CAMTA1 antisense RNA 3 (CAMTA1-AS3)
- Target
- CAMTA1-AS3
- Molecular classification
- Long non-coding RNA (lncRNA), Antisense RNA
01
Overview
CAMTA1 antisense RNA 3 (CAMTA1-AS3) is a long non-coding RNA (lncRNA) transcribed antisense to the CAMTA1 gene. As an antisense RNA, it may regulate the expression of CAMTA1, which encodes a calmodulin-binding transcription activator involved in neural development and tumor suppression[2][3]. CAMTA1-AS3 itself has no known protein-coding capacity and, as of now, lacks direct evidence for a defined biological or disease-related role. There are no known therapeutics, biomarkers, or drug interactions directly associated with CAMTA1-AS3. The molecule is best categorized as a regulatory non-coding RNA without current evidence supporting its status as a therapeutic target or as a classical druggable entity[2][3].
- Other names
- AL512330.1CAMTA1-AS3
02
Biological functions
Likely regulation of CAMTA1 gene expression via antisense interactionPotential regulatory role in gene expression (inferred from classification as antisense lncRNA[2][3])Other
03
Disease associations
No direct evidence for involvement in specific diseases as a direct functional targetPotential but unverified role in diseases involving dysregulation of CAMTA1 (e.g., cancer, neurological disorders), inferred from the nature of antisense RNAs and the functions of CAMTA1 itself[2][3]
Beyond the preview
Go deeper on CAMTA1 antisense RNA 3 (CAMTA1-AS3).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CAMTA1 antisense RNA 3 (CAMTA1-AS3).